|
||||||
GENERAL
The Journal of the Serbian Chemical Society is an international journal publishing papers from all fields of chemistry and related disciplines. Twelve issues are published annually.
The Editorial Board expects the editors, reviewers and authors to respect the well-known standard of professional ethics.
Types of Contributions
|
Original scientific papers |
(about 10 typewritten pages) report original research which must not have been previously published. |
|
Short communications |
(about 5 pages) report unpublished preliminary results of sufficient importance to merit rapid publication. |
|
Notes |
(about 3 pages) report unpublished results of short, but complete, original research |
|
Authors’ reviews |
(about 30 pages) present an overview of the author’s current research with comparison to data of other scientists working in the field |
|
Reviews |
(about 30 pages) present a concise and critical survey of a specific research area. Generally, these are prepared at the invitation of the Editor |
|
Book and Web site reviews |
(1 ‑ 2 pages) |
|
Extended abstracts |
(about 3 pages) of Lectures given at meetings of the Serbian Chemical Society Divisions |
Submission of manuscripts
Manuscripts should be submitted using the OnLine Submission Form, available on the JSCS Web Site (www.shd.org.rs/JSCS/Form/). The manuscript must be uploaded as a Word.doc or .rtf file (tables and figures should follow the text, each on a separate page). Illustrations in TIF or EPS format (JPG format is acceptable for colour and greyscale photos, only), must be additionally uploaded as a separate archived (.zip, .rar or .arj) file. Figures and/or Schemes should be prepared according to the Artwork Instructions !
Manuscripts must be accompanied by a cover letter in which the type of the submitted manuscript and a warranty as given below are given. The Author warranties that the manuscript submitted to the Journal for review is original, has been written by the stated authors and has not been published elsewhere; is currently not being considered for publication by any other journal and will not be submitted for such a review while under review by the Journal; the manuscript contains no libellous or other unlawful statements and does not contain any materials that violate any personal or proprietary rights of any other person or entity. All manuscripts will be acknowledged on receipt (by e-mail) and given a reference number, which should be quoted in all subsequent correspondence. A password for “Article Tracking” (www.shd.org.rs/JSCS/) will also be supplied
A MANUSCRIPT NOT PREPARED
ACCORDING TO THESE INTRUCTIONS WILL BE RETURNED
FOR RESUBMITION WITHOUT BEING ASSIGNED A REFERENCE NUMBER.
Conflict-of-Interest Statement*: Public trust in the peer review process and the credibility of published
articles depend in part on how well conflict of interest is handled during
writing, peer review, and editorial decision making. Conflict of interest
exists when an author (or the author's institution), reviewer, or editor has
financial or personal relationships that inappropriately influence (bias) his
or her actions (such relationships are also known as dual commitments,
competing interests, or competing loyalties). These relationships vary from
those with negligible potential to those with great potential to influence
judgment, and not all relationships represent true conflict of interest. The
potential for conflict of interest can exist whether or not an individual
believes that the relationship affects his or her scientific judgment.
Financial relationships (such as employment, consultancies, stock ownership,
honoraria, paid expert testimony) are the most easily identifiable conflicts of
interest and the most likely to undermine the credibility of the journal, the
authors, and of science itself. However, conflicts can occur for other reasons,
such as personal relationships, academic competition, and intellectual passion.
Informed Consent Statement*: Patients have a right to privacy that should not be infringed without
informed consent. Identifying information, including patients' names, initials,
or hospital numbers, should not be published in written descriptions,
photographs, and pedigrees unless the information is essential for scientific
purposes and the patient (or parent or guardian) gives written informed consent
for publication. Informed consent for this purpose requires that a patient who
is identifiable be shown the manuscript to be published. Authors should
identify Individuals who provide writing assistance and disclose the funding
source for this assistance. Identifying
details should be omitted if they are not essential. Complete anonymity is
difficult to achieve, however, and informed consent should be obtained if there
is any doubt. For example, masking the eye region in photographs of patients is
inadequate protection of anonymity. If identifying characteristics are altered
to protect anonymity, such as in genetic pedigrees, authors should provide
assurance that alterations do not distort scientific meaning and editors should
so note. The requirement for informed
consent should be included in the journal's instructions for authors. When
informed consent has been obtained it should be indicated in the published
article.
Human and Animal Rights
Statement*: When reporting experiments on human subjects,
authors should indicate whether the procedures followed were in accordance with
the ethical standards of the responsible committee on human experimentation
(institutional and national) and with the Helsinki Declaration of 1975, as
revised in 2000 (5). If doubt exists whether the research was conducted in
accordance with the Helsinki Declaration, the authors must explain the
rationale for their approach, and demonstrate that the institutional review
body explicitly approved the doubtful aspects of the study. When reporting
experiments on animals, authors should be asked to indicate whether the
institutional and national guide for the care and use of laboratory animals was
followed.
*
International Committee of Medical Journal Editors ("Uniform Requirements
for Manuscripts Submitted to Biomedical Journals") -- February 2006
PROCEDURE
All contributions will be peer reviewed and only those deemed worthy will be accepted for publication. The Editor has the final decision. To facilitate the reviewing process, authors are encouraged to suggest up to three persons competent to review their manuscript. Such suggestions will be taken into consideration but not always accepted.
Manuscripts requiring revision should be returned according to the requirement of the Editor, within 60 days or the manuscript will be considered as having been withdrawn. Later, the manuscript would have to be resubmitted.
The Journal maintains its policy and takes the liberty of correcting the English of manuscripts scientifically accepted for publication.
When a manuscript is ready for printing, the corresponding author will receive a PDF-formatted manuscript for proof reading, which should be returned to the Journal within 2 days. Failure to do so will be taken as the authors are in agreement with any alteration which may have occurred during the preparation of the manuscript.
Accepted manuscripts of active members of the Serbian Chemical Society (all authors) have publishing priority.
The corresponding author will receive by e-mail a PDF-formatted version of the paper as published in the journal.
MANUSCRIPT PRESENTATION
Manuscripts should be typed in English (either standard British or American English, but consistent throughout) with 1.5 spacing (12 points Times New Roman; Greek letters in the character font Symbol) in A4 format leaving 2.5 cm for margins. For Regional specific, non-standard save documents with Embed fonts Word option: Save as -> (Tools) -> Save Options… -> Embed fonts in the text.
The authors are requested to seek the assistance of competent English language expert, if necessary, to ensure their English is of a reasonable standard. The Serbian Chemical Society can provide this service in advance of submission of the manuscript. If this service is required, please contact the office of the Society by e-mail (jscs-info@shd.org.rs).
Tables and figures and/or schemes should not be embedded in the manuscript but their position in the text indicated. In electronic version (Word.doc document) tables and figures and/or schemes should follow the text, each on a separate page. Please number all pages of the manuscript including separate lists of references, tables and figures and their captions.
IUPAC recommendations for the naming of compounds should be followed. SI units, or other permissible units, should be employed. The designation of physical quantities must be in italic throughout the text (including figures, tables and equations), whereas the units and indexes (except for indexes having the meaning of physical quantities) are in upright letters. They should be in Times New Roman font. In graphs and tables, a slash should be used to separate the designation of a physical quantity from the unit (example: p / kPa, j / mA cm-1°C, T0 / K, t / h…). Designations such as: p (kPa), t [min]…, are not acceptable. However, if the full name of a physical quantity is unavoidable, it should be given in upright letters and separated from the unit by a comma (example: Pressure, kPa; Temperature, K; Current density, mA cm-1…).. Please do not use the axes of graphs for additional explanations; these should be mentioned in the figure captions and/or the manuscript (example: “pressure at the inlet of the system, kPa” should be avoided). The axis name should follow the direction of the axis (the name of y‑axis should be rotated by 90°). Top and right axes should be avoided in diagrams, unless they are absolutely necessary.
Latin words, as well as the names of species, should be in italic, as for example: i.e., e.g., in vivo, ibid, Calendula officinalis L., etc. The branching of organic compound should also be indicated in italic, for example, n-butanol, tert-butanol, etc.
Decimal numbers must have decimal points and not commas in the text (except in the Serbian abstract), tables and axis labels in graphical presentations of results. Thousands are separated, if at all, by a comma and not a point.
ARTICLE STRUCTURE
- TITLE PAGE
- MAIN TEXT
- TABLE CAPTIONS
- TABLES (each on a
separate page)
- FIGURE and/or SCHEME
CAPTIONS
- FIGURES and/or SCHEMES
(each on a separate page)
Title page
Title in bold letters, should be clear and concise, preferably 12 words or less. The use of non-standard abbreviations, symbols and formulae is discouraged.
AUTHORS’ NAMES in capital letters with the full first name, initials of further names separated by a space and surname. Commas should separate the author’s names except for the last two names when ‘and’ is to be used. In multi-affiliation manuscripts, the author’s affiliation should be indicated by an Arabic number placed in superscript after the name and before the affiliation. Use * to denote the corresponding author(s).
Affiliations should be written in italic. The e-mail address of the corresponding author should be given after the affiliation(s).
Abstract: A one-paragraph abstract written of 150 – 200 words in an impersonal form indicating the aims of the work, the main results and conclusions should be given and clearly set off from the text. Domestic authors should also submit, on a separate page, an Abstract - Izvod, the author’s name(s) and affiliation(s) in Serbian (Latin letters). For authors outside Serbia, the Editorial Board will provide a Serbian translation of their English abstract.
Keywords: Up to 6 keywords should be given. Do not use words appearing in the manuscript title
RUNNING TITLE: A one line (maximum five words) short title in capital letters should be provided.
Main text
The main text should have the form:
INTRODUCTION,
EXPERIMENTAL (RESULTS AND DISCUSSION)
RESULTS AND DISCUSSION (EXPERIMENTAL)
CONCLUSIONS
NOMENCLATURE (optional)
Acknowledgements: If any.
REFERENCES (Citation of recent papers published in chemistry journals that highlight the significance of work to the general readership is encouraged.)
The sections should be arranged in a sequence generally accepted for publication in the respective fields. They subtitles should be in capital letters, centred and NOT numbered.
The INTRODUCTION should include the aim of the research and a concise description of background information and related studies directly connected to the paper.
The EXPERIMENTAL section should give the purity and source of all employed materials, as well as details of the instruments used. The employed methods should be described in sufficient detail to enable experienced persons to repeat them. Standard procedures should be referenced and only modifications described in detail.
On no account should results be included in the experimental section.
The RESULTS AND DISCUSSION should include concisely presented results and there significance discussed and compared to relevant literature data. The results and discussion may be combined or kept separate.
The inclusion of a CONCLUSION section, which briefly summarizes the principal conclusions, is highly recommended.
NOMENCLATURE is optional but, if the authors wish, a list of employed symbols may be included.
REFERENCES should be numbered sequentially as they appear in the text. When cited in the text, the reference number should be superscripted in Font 12, following any punctuation mark. In the reference list, they should be in normal position followed by a full stop. Reference entry must not be formatted using Carriage returns (enter key; 8 key) or multiple space key. The formatting of references to published work should follow the Journal’s style as follows:
|
Journals*: |
1. A. B. Surname1, C. D. Surname2, J. Serb. Chem. Soc. Vol (Year) first page Number |
|
Books: |
2. A. B. Surname1, C. D. Surname2, Name of Book, Publisher, City, Country, Year, p. 100 |
|
Compilations: |
3. A. B. Surname1, C. D. Surname2, in Name of Compilation, A. B. Editor1, C. D. Editor2, Ed(s)., Publisher, City, Country, Year, p. 100 |
|
Proceedings: |
4. A. B. Surname1, C. D. Surname2, Title of the Proceeding, in Proceeding of Name of the Conference or Symposium, (Year), Place of the Conference, Country, Year, p. 100 |
|
Patents: |
5. A. B. Inventor1, C. D. Inventor2, (Holder), Country Code and patent number (registration year) |
|
Chemical |
6. A. B. Surname1, C. D. Surname2, Chem. Abstr. CA 234 567a For non-readily available literature, the Chemical Abstracts reference should be given in square brackets: [C.A. 139/2003 357348t] after the reference |
|
Standards: |
7. EN ISO 250: Name of the Standard (Year) |
|
Websites: |
8. Title of the website, URL in full, (date accessed) |
* When citing Journals, the International Library Journal abbreviation is required. Please consult e.g. http://www.library.ubc.ca/scieng/coden.html
Only the last entry in the reference list should end with a full stop.
The names of all authors should be given in the list of references; the abbreviation et al. may only be used in the text. The original journal title is to be retained in the case of publications published in any language other than English (please denote the language in parenthesis after the reference). Titles of publications in non-Latin alphabets should be transliterated. Russian references are to be transliterated using the following transcriptions:
ж→zh, ҳ→kh, ц→ts, ч→ch, ш→sh, щ→shch, ы→y, ю→yu, я→ya, э→e, й→i, ь→’.
Table Captions
A separate list of table captions, which makes the tables comprehensible without reference to the text, should be provided in numerical order on a separate page
Tables
Tables are part of the text but must
be given on separate pages. The tables should be numbered consequently in Roman
numbers. Quantities should be separated from units by a slash (/). Footnotes to
tables, in size 10 font, are to be indicated consequently (line-by-line) in
superscript letters. Tables should be prepared with the aid of the WORD table
function, without vertical lines. The minimum size of the font in the tables
should be 10 pt. Table columns must not be formatted using multiple spaces.
Table rows must not be formatted using Carriage returns (enter key; 8 key). Tables should not be incorporated as
graphical objects.
In setting up tables, Authors should keep in mind the
area of the Journal’s page (12.5 cm × 19 cm) and should make tables conform to
the limitations of these dimensions.
Figure and/or Scheme Captions
A separate list of figure and /or scheme captions, which makes the figures and/or schemes comprehensible without reference to the text, should be provided in numerical order on a separate page
Figures and/or Schemes
Figures and/or Schemes (in low resolution) should follow the captions, each on a separate page of the manuscript. High resolution illustrations in TIF or EPS format (JPG format is acceptable for colour and greyscale photos, only) must be uploaded as a separate archived (.zip, .rar or .arj) file.
Figures and/or Schemes should be prepared according to the ARTWORK INSTRUCTIONS!
Mathematical and chemical equations must be numbered, Arabic numbers, consecutively in parenthesis at the end of the line. All equations should be embedded in the text except when they contain graphical elements (tables, figures, schemes and formulae). Complex equations (fractions, inegrals, matrix…) should be prepared with the aid of the WORD Equation editor.
Reporting analytic and spectral data
Adequate evidence to enable the identity and purity of all newly synthesized compounds should be provided.
The styles for the presentation of analytical and spectral data, which should be strictly adhered to (including the order), are as follows:
Compound (3a): Yield: 60 %; m.p. 120 °C; Anal. Calcd. for C30H23N3O5: C, 71.27; H 4.58; N, 8.31. Found: C, 71.30, H, 4.54, N, 8.70; IR (KBr, cm-1): 1535, 1469 (C=C- stretching of aromatic ring), 1680s (-C=O stretching of -COOH group), 3128 (-NH stretching of secondary amine); 1H-NMR (200 MHz, DMSO-d6, δ / ppm): 1.38-1.39 (3H, t, -CH2-CH3), 4.0-4.49 (2H, q, -CH2-CH3), 10.92 (1H, s, -NH, D2O exchangeable), 7.75 (2H, t, aromatic, J = 7.8 Hz), 2.26-2.75 (2H, m, -CH2); 13C-NMR (100 MHz, CDCl3, δ / ppm): 157.76 (C1), 146.89 (C2), 177.69 (-COO), 33.44 (-CH), 38.55 (-CH2); MS (m/z, (relative abundance, %)): 252 (M+, 32.5) 225, 213, 211 (BP, 100); UV-Vis (EtOH) (λmax / nm, eV or cm-1 (ε / L mol-1 cm-1)): 205 (2300), 243 (1800); Optical rotation values, α (589 nm, 20 oC, 10 g dm-3 in H2O, 10 cm): +66.470o; Specific rotation [α]20589 / deg dm-1 g-1 cm3; Magnetic moment, μeff, μB : 3.1.
Deposition of crystallographic data
Prior to submission, the crystallographic data included in a manuscript presenting such data should be deposited at the appropriate database. Crystallographic data associated with organic and metal-organic structures should be deposited at the Cambridge Crystallographic Data Centre (CCDC) by e-mail to deposit@ccdc.cam.ac.uk.
Crystallographic data associated with inorganic structures should be deposited with the Fachinformationszentrum Karlsruhe (FIZ) by e-mail to crysdata@fiz-karlsruhe.de. A deposition number will then be provided, which should be added to the reference section of the manuscript.